Beigene Stock Fundamentals
| BGNE Stock | USD 190.30 0.21 0.11% |
BeiGene fundamentals help investors to digest information that contributes to BeiGene's financial success or failures. It also enables traders to predict the movement of BeiGene Stock. The fundamental analysis module provides a way to measure BeiGene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BeiGene stock.
At present, BeiGene's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 1.5 B, whereas Net Loss is forecasted to decline to (1 B). BeiGene | Select Account or Indicator |
BeiGene Company Operating Margin Analysis
BeiGene's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current BeiGene Operating Margin | (0.14) % |
Most of BeiGene's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BeiGene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
BeiGene Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, BeiGene has an Operating Margin of -0.139%. This is 99.6% lower than that of the Biotechnology sector and 99.88% lower than that of the Health Care industry. The operating margin for all United States stocks is 97.48% lower than that of the firm.
BeiGene Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BeiGene's current stock value. Our valuation model uses many indicators to compare BeiGene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BeiGene competition to find correlations between indicators driving BeiGene's intrinsic value. More Info.BeiGene is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . At present, BeiGene's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value BeiGene by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.BeiGene Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BeiGene's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BeiGene could also be used in its relative valuation, which is a method of valuing BeiGene by comparing valuation metrics of similar companies.BeiGene is currently under evaluation in operating margin category among its peers.
BeiGene Current Valuation Drivers
We derive many important indicators used in calculating different scores of BeiGene from analyzing BeiGene's financial statements. These drivers represent accounts that assess BeiGene's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of BeiGene's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 10.0B | 21.6B | 25.1B | 22.7B | 18.8B | 19.8B | |
| Enterprise Value | 9.6B | 20.7B | 21.5B | 19.7B | 16.6B | 17.4B |
BeiGene ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, BeiGene's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to BeiGene's managers, analysts, and investors.Environmental | Governance | Social |
BeiGene Fundamentals
| Return On Equity | -0.23 | ||||
| Return On Asset | -0.0958 | ||||
| Profit Margin | (0.26) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | 19.63 B | ||||
| Shares Outstanding | 97.77 M | ||||
| Shares Owned By Insiders | 17.79 % | ||||
| Shares Owned By Institutions | 44.97 % | ||||
| Number Of Shares Shorted | 1.09 M | ||||
| Price To Earning | (16.19) X | ||||
| Price To Book | 5.91 X | ||||
| Price To Sales | 0.90 X | ||||
| Revenue | 2.46 B | ||||
| Gross Profit | (511.06 M) | ||||
| EBITDA | (1.12 B) | ||||
| Net Income | (881.71 M) | ||||
| Cash And Equivalents | 5.7 B | ||||
| Cash Per Share | 55.17 X | ||||
| Total Debt | 930.18 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 4.54 X | ||||
| Book Value Per Share | 226.72 X | ||||
| Cash Flow From Operations | (1.16 B) | ||||
| Short Ratio | 2.93 X | ||||
| Earnings Per Share | (8.19) X | ||||
| Target Price | 277.61 | ||||
| Number Of Employees | 10.6 K | ||||
| Beta | 0.63 | ||||
| Market Capitalization | 21.23 B | ||||
| Total Asset | 5.81 B | ||||
| Retained Earnings | (7.96 B) | ||||
| Working Capital | 2.39 B | ||||
| Current Asset | 106.27 M | ||||
| Current Liabilities | 35.17 M | ||||
| Net Asset | 5.81 B |
About BeiGene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BeiGene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BeiGene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BeiGene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 300 K | 285 K | |
| Total Revenue | 2.5 B | 2.6 B | |
| Cost Of Revenue | 379.9 M | 746.8 M | |
| Stock Based Compensation To Revenue | 0.15 | 0.14 | |
| Sales General And Administrative To Revenue | 0.89 | 0.84 | |
| Research And Ddevelopement To Revenue | 0.72 | 0.69 | |
| Capex To Revenue | 0.24 | 0.22 | |
| Revenue Per Share | 23.55 | 24.73 | |
| Ebit Per Revenue | (0.49) | (0.52) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:Check out BeiGene Piotroski F Score and BeiGene Altman Z Score analysis. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.19) | Revenue Per Share 225.239 | Quarterly Revenue Growth 0.395 | Return On Assets (0.1) | Return On Equity (0.23) |
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.